| Patent Number |
Title Of Patent |
Date Issued |
| RE29480 |
Method for determining vitamin B.sub.12 and reagent therefor |
November 22, 1977 |
| Method for determining vitamin B.sub.12 in aqueous samples by contacting said sample with radioactivity labelled vitamin B.sub.12 and with particles of water insoluble polymers to which substances capable of binding vitamin B.sub.12 have been bound, thereafter separating said particl |
| RE29474 |
Method for the determination of proteins and polypeptides |
November 15, 1977 |
| A process comprising contacting particles of water insoluble polymers to which have been bound antibodies, by means of covalent bonds, against the protein or polypeptide to be determined, wherein a certain quantity of the protein or polypeptide is labeled with a radioactive isotope, wher |
| D486908 |
Snap-on grip for an injector |
February 17, 2004 |
|
| D476734 |
Injector |
July 1, 2003 |
|
| D476078 |
Injector |
June 17, 2003 |
|
| D471976 |
Injector |
March 18, 2003 |
|
| D467414 |
Container for medical instruments |
December 24, 2002 |
|
| D455209 |
Injection device |
April 2, 2002 |
|
| D453569 |
Injection device |
February 12, 2002 |
|
| D392802 |
Storage box with mouth-piece and blister package |
March 31, 1998 |
|
| D382474 |
Dispensing housing with blister package |
August 19, 1997 |
|
| D368961 |
Multiple dose injector |
April 16, 1996 |
|
| D299699 |
Cap for containers |
February 7, 1989 |
|
| D298651 |
Nomogram for calculating the maximum tolerable blood loss of a patient |
November 22, 1988 |
|
| 7232894 |
Method for the production of recombinant peptides with a low amount of trisulfides |
June 19, 2007 |
| Methods for the production of recombinant peptides comprise fermenting cells to produce recombinant peptides. A metal salt is added to a concentrate of the fermented cells after the fermentation step, prior to peptide isolation, and the pH of the cell concentrate after the addition o |
| 7229965 |
Use of growth hormone in low dose |
June 12, 2007 |
| The invention relates to treatment of patients in need of increasing insulin sensitivity by administration of growth hormone or analogues thereof, preferably human growth hormone, in a low dose and the use of growth hormone or analogues thereof, preferably human growth hormone, for t |
| 7164133 |
Delivery device and method for its operation |
January 16, 2007 |
| A system of marked medical containers comprises at least two containers having different properties in at least one respect, and at least one machine-readable marking on each of the containers, each marking being designed to allow discrimination between the difference in properties. |
| 7122515 |
Methods for treating a patient having Metabolic Syndrome |
October 17, 2006 |
| A method for treating a patient having Metabolic Syndrome comprising Primary Insulin Resistance and exhibiting lipoprotein aberrations or hypertension comprises administering to said patient human growth hormone or a functional analog thereof in an amount effective for decreasing lip |
| 7104971 |
Medical device |
September 12, 2006 |
| The invention relates to an injector device for delivery of liquid from a high pressure source, and also to a method of performing such an injection. The device comprises a storage chamber 6, for the liquid or the liquid precursor components, comprising a storage barrel 16 with at le |
| 7041450 |
Method for diagnosing GH deficiency |
May 9, 2006 |
| The present invention relates to a method and kit for diagnosing GH (growth hormone) deficiency, in particular isolated growth hormone deficiency II (IGHD II). The method comprises the steps of analysing the missense mutation G.sup.6191 to T in exon 4 of GH-1 which changes valine 110 |
| 7033337 |
Medical device |
April 25, 2006 |
| The invention relates to an injector device for delivery of liquid from a high pressure source, and also to a method of performing such an injection. The device comprises a storage chamber 6, for the liquid or the liquid precursor components, comprising a storage barrel 16 with at le |
| 6911217 |
Controlled release bead, a method of producing the same and multiple unit formulation comprising |
June 28, 2005 |
| A controlled release bead comprises: (i) a core unit of a substantially water-soluble or water-swellable inert material; (ii) a first layer on the core unit of a substantially water-insoluble polymer; (iii) a second layer covering the first layer and containing an active ingredient; and |
| 6891025 |
Modified cytokine receptor protein |
May 10, 2005 |
| A modified extracellular domain of a cytokine receptor is capable of being crystallized without being complexed to a ligand molecule. The receptor preferably is a homo- or heterodemeric receptor having at least one molecule segment which contributes to a disorder structure deleted. A |
| 6858846 |
Delivery device and method for its operation |
February 22, 2005 |
| Provided is a method for operating a preparation delivery device wherein the device comprises a) a container for the preparation having, or being prepared for the arrangement of, an opening, b) a mechanism operable to deliver at least part of the preparation in the container through the |
| 6846800 |
Method for treating a patient having metabolic syndrome |
January 25, 2005 |
| Methods for treating a patient for insulin resistance to decrease the insulin resistance in a patient having Metabolic Syndrome comprising Primary Insulin Resistance and abdominal/visceral obesity comprise administering to the patient growth hormone or a functional derivative thereof |
| 6807797 |
Prefilled ampoules and manufacture thereof |
October 26, 2004 |
| A syringe type ampoule having a) a barrel with a front end and a rear end defining an axis therebetween, the barrel having substantially constant cross-section between the front end and the rear end, at least the front end ending in an opening, b) a sealer attached to the front end and |
| 6790998 |
Phenyl inden-1-one compounds |
September 14, 2004 |
| The invention relates to a process for the enantioselective preparation of tolterodine and analogues and salts thereof comprises the steps of: a) enantioselectively reducing the carbonyl function in a compound of formula (II): ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 independe |
| 6770295 |
Therapeutic formulation for administering tolterodine with controlled release |
August 3, 2004 |
| The present invention is drawn to a method of treating an unstable or overactive urinary bladder by treating the patient with tolterodine or a tolterodine-related compound, or pharmaceutically acceptable salt thereof, with a controlled release formulation that maintains a substantially |
| 6767994 |
Process for purifying a compound |
July 27, 2004 |
| The present invention relates to a process for purifying a hydrophobic or amphiphilic compound, by first mixing a starting material containing the hydrophobic or amphiphilic compound with a first polymeric material, water and at least one of a second polymeric material and a surfactant, |
| 6758837 |
Liquid delivery device and method of use thereof |
July 6, 2004 |
| A device and use method for ejecting a liquid stream towards an eye, the stream moving from a proximal position towards a distal position, the device comprising a) a housing, b) a container for the liquid, c) at least one opening arranged for ejection of the stream and being in fluid |
| 6740062 |
Medical device |
May 25, 2004 |
| The invention relates to an injector device for delivery of liquid from a high pressure source, and also to a method of performing such an injection. The device comprises a storage chamber 6, for the liquid or the liquid precursor components, comprising a storage barrel 16 with at least |
| 6730066 |
Liquid delivery container |
May 4, 2004 |
| Pressurisable container for storing and ejecting liquid, the container comprising a) a front wall having or surrounding a cavity corresponding to the form of an open vessel, b) an opening in the front wall adapted for ejection of the liquid from the container, said opening defining a |
| 6709416 |
Arrangement in electronically controlled injection devices |
March 23, 2004 |
| In an electronically controlled injection device for the administering of one or more injections from an injection cartridge, the readying of the device for administrating and the subsequent administering therefrom are controlled by an electronic control unit. This control unit comprises |
| 6696414 |
Use of growth hormone in low dose |
February 24, 2004 |
| The invention relates to treatment of patients in need of increasing insulin sensitivity by administration of growth hormone or analogues thereof, preferably human growth hormone, in a low dose and the use of growth hormone or analogues thereof, preferably human growth hormone, for t |
| 6689916 |
Phenyl propenone compounds |
February 10, 2004 |
| The invention relates to a process for the enantioselective preparation of tolterodine and analogues and salts thereof comprises the steps of: a) enantioselectively reducing the carbonyl function in a compound of formula (II): ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 independentl |
| 6689101 |
Medical arrangement |
February 10, 2004 |
| An injector device for delivery of liquid from a high pressure, the device comprising a housing, a pressure chamber 2 comprising a pressure barrel 4 for accommodation of at least one piston therein and having a front end opening 6 for ejection of the liquid, the pressure chamber being of |
| 6680181 |
Production of peptides |
January 20, 2004 |
| The invention relates to a method for the production of recombinant peptides by fed-batch cultivation of a microorganism in a bioreactor containing a medium comprising organic carbon source, nitrogen source and mineral salts. The cultivation is carried out by the addition of the orga |
| 6676959 |
Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
January 13, 2004 |
| Formulations of nicotine for use in nicotine replacement therapy. The formulations are intended for application in the oral cavity where upon the uptake of nicotine mainly takes place through the buccal mucosa. The formulations essentially comprise apolar, polar and surface-active co |
| 6664534 |
Tilt sensing device and method for its operation |
December 16, 2003 |
| A tilt sensing device and method for its operation, the device being of the type comprising a) a housing, b) a radiation transmitter and a radiation receiver arranged in or at the housing to form a beam path therebetween, c) a radiation obstructing or deflecting body movable in relation |
| 6634076 |
Structure and method for joining parts |
October 21, 2003 |
| The invention relates to an article of manufacture comprising a partial or complete tubular primary part defining a tube axis and having an at least partially curved circumferential wall at least partially encircling the axis; said wall comprising a joint edge, defining a) a joint line a |
| 6630162 |
Pharmaceutical formulation and its use |
October 7, 2003 |
| The invention relates to a pharmaceutical formulation containing tolterodine or a tolterodine-related compound, or a pharmacologically acceptable salt thereof, as active ingredient, in which the formulation exhibits a controlled in vitro release of the active ingredient in phosphate |
| 6620428 |
Transdermally administered acetylcysteine as mucolytic agent |
September 16, 2003 |
| Device for transdermal administration of N-Acetyl-L-cysteine, optionally encompassing salts, prodrugs and metabolites thereof, optionally together with pharmaceutically acceptable carrier(s) to a human being or an animal in order to achieve a mucolytic effect. Use of a mucolytic compound |
| 6605706 |
Method for producing a correctly folded, biological active recombinant protein |
August 12, 2003 |
| Methods for producing correctly folded biological active recombinant protein or polypeptide comprise the steps of expressing the protein or polypeptide in prokaryotic cells, harvesting the cells, directly solubilizing the cells in a buffer at pH of about 8 to 11 with the chaotropic a |
| 6599272 |
Injection device and method for its operation |
July 29, 2003 |
| Injector devices and methods for their operation for containers having an opening with or for an injection needle. The container is optionally of syringe type with a barrel of substantially constant axial cross-section. In one embodiment, the devices include a penetration arrangement ope |
| 6566537 |
Process and intermediates |
May 20, 2003 |
| The invention relates to a process for the enantioselective preparation of tolterodine and analogues and salts thereof comprises the steps of: a) enantioselectively reducing the carbonyl function in a compound of formula (II): ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 independe |
| 6562006 |
Injector device and method for its operation |
May 13, 2003 |
| Injector device, and method for its operation, for containers of syringe type, comprising a barrel of axially roughly constant cross-section, a front opening and at least one movable wall inserted in the barrel for displacement of a container content, the injector comprising a) a housing |
| 6559120 |
Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and ho |
May 6, 2003 |
| A recombinant DNA molecule comprising a nucleotide sequence (I) which codes for a polypeptide displaying the antigenicity of one, two or more of the Phi p I epitope clones (28, 34, 41, 42, 43, 45, 50, 52, 64, 80, 85, 86, 95, 97, 98, 103, 108, 109, 113, 114), with the amino acid sequences |
| 6558395 |
Intraocular lens implanter |
May 6, 2003 |
| A device for deforming and ejecting a deformable intraocular lens for insertion into a small incision in an eye, the device comprising a) a housing, b) a lens transporting duct in a front part of the housing defining a duct axis, the duct having a front end with a cross-section adapt |
| 6547755 |
Automated delivery device and method for its operation |
April 15, 2003 |
| A delivery device including a) a housing, b) a container for a fluid arranged in the housing, the container having an opening, c) a delivery conduit connected in fluid communication with the opening, the conduit having a front end in flow respect distal from the container and a rear |
| 6537795 |
Method and means for the production of hyaluronic acid |
March 25, 2003 |
| A method for selecting streptococcus strains capable of producing hyaluronic acid with molecular weight exceeding six million includes the steps of cultivating strains of streptococci individually in culture medium which is free of metal ions which promote degradation of hyaluronic a |
